Search
for
Sort by
Research 181–210 of 1000+
- DRUG‐ASSOCIATED ALOPECIA
- Resident T cell activation leads to human hair follicle immune privilege loss ex vivo, which is prevented by the DHODH inhibitor farudodstat: relevance for alopecia areata
- 4‐octyl itaconate alleviates cisplatin‐induced ferroptosis possibly via activating the NRF2/HO‐1 signalling pathway
- Roaccutane induced acute liver failure
- Chemical Screening for Hair Cell Loss and Protection in the Zebrafish Lateral Line
- Alopecia caused by isoniazid
- Adverse Cutaneous Reactions to Antipsychotics
- A Review on-Types and Treatment of Alopecia
- Oral minoxidil in trichology: A review
- Therapeutic effects of topical Mycophenolate mofetil on hydroquinone-induced depigmentation in Guinea pigs and mice
- Drug Repurposing Patent Applications April–June 2021
- Hair and Nail Manifestations of Systemic Disease
- Cutaneous complications of chemotherapeutic agents
- The Pathogenesis of Primary Cicatricial Alopecias
- Hair growth-modulation by adrenergic drugs
- Long-term sequelae of drug reaction with eosinophilia and systemic symptoms: A retrospective cohort study from Taiwan
- Minoxidil-induced hypertrichosis: treatment with calcium thioglycolate depilatory.
- Case Report: Diffuse Hypertrichosis in the Course of Hepatitis C Treatment by IFN-<i>α</i> and Ribavirin
- Finasteride-induced depression: new insights into possible pathomechanisms
- Immortalized human hair follicle-derived mesenchymal-like stromal cells for the long-term production of scalable Immunomodulatory and regenerative secretome
- Minoxidil induced hypertrichosis in children
- Nilontinib induced keratosis pilaris atrophicans
- Cutaneous Side Effects of Chemotherapy and Radiotherapy
- Black phosphorus nanosheets encapsulated microneedle for multifunctional therapy for androgenic alopecia
- TOC
- Alopecia in general medicine
- Dissolving microneedles: Applications and growing therapeutic potential
- Ganoderma lucidum ethanolic extract for the treatment of androgenic alopecia in rats with testosterone-induced Baldness.
- Pooled safety and tolerability data from four placebo-controlled teriflunomide studies and extensions
- Cutaneous manifestations associated with substance use disorders